SWM
AZN icon

Seed Wealth Management’s AstraZeneca AZN Stock Holding History

Seed Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Hold
1,170
– – 0.14% 91
2026
Q1 		$231K Hold
1,170
– – 0.16% 90
2025
Q4 		$215K Buy
+1,170
New +$205K 0.15% 94

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Seed Wealth Management's AZN Position: Q2 2026 in Review

Seed Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 1,170 shares worth $222K. The position accounts for 0.14% of the portfolio, ranked #91.

Seed Wealth Management first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $231K in Q1 2026. 488 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Seed Wealth Management held 1,170 shares of AstraZeneca worth $222K as of Q2 2026.
  • Seed Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.14% of Seed Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Seed Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Seed Wealth Management's AstraZeneca position peaked at $231K in Q1 2026.
  • 488 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Seed Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.